iSpecimen Inc (ISPC)
4.56
-0.37
(-7.51%)
USD |
NASDAQ |
Nov 05, 16:00
4.49
-0.07
(-1.54%)
After-Hours: 16:27
iSpecimen Shareholders Equity (Quarterly): 6.089M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 6.089M |
| March 31, 2024 | 6.813M |
| December 31, 2023 | 9.741M |
| September 30, 2023 | 12.71M |
| June 30, 2023 | 14.71M |
| March 31, 2023 | 18.08M |
| December 31, 2022 | 20.31M |
| September 30, 2022 | 22.42M |
| June 30, 2022 | 25.30M |
| Date | Value |
|---|---|
| March 31, 2022 | 27.67M |
| December 31, 2021 | 29.79M |
| September 30, 2021 | 12.09M |
| June 30, 2021 | 10.68M |
| March 31, 2021 | -31.22M |
| December 31, 2020 | -27.28M |
| September 30, 2020 | -25.70M |
| December 31, 2019 | -22.72M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-31.22M
Minimum
Mar 2021
29.79M
Maximum
Dec 2021
6.441M
Average
12.09M
Median
Sep 2021
Shareholders Equity (Quarterly) Benchmarks
| RadNet Inc | 880.97M |
| 23andMe Holding Co | 143.50M |
| Delcath Systems Inc | 4.192M |
| CytoSorbents Corp | 16.74M |
| Progyny Inc | 456.19M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 11.90M |
| Total Liabilities (Quarterly) | 5.813M |
| Current Ratio | 0.9007 |